Secure–Privacy–Ethical–Legal Governance Framework for Triage-Centric Telemedicine Workflows

When the development of Information and Communication Technologies (ICT) [1] spread widely into all the domains, one of the domains is telemedicine [2], also called healing at a distance. Initially, telemedicine was started in the 1970s with the support of the telephone, mail conversation [3]. Later, the World Health Organization (WHO) defined the term telemedicine/telemedicine by means of providing the treatment over a distance with the support of ICT equipment like communication devices, the Internet, Medical equipment, etc. [4]. WHO defines health innovation as improving systems, products, technologies, services, and policies, especially for vulnerable populations. Even the promotion and usage of telemedicine technology was accepted after the COVID-19 period [5]. When the electric and internet facilities are incorporated into the telemedicine, it leads the device to be vulnerable to security and privacy issues. Ethical and legal issues play a major role in assuring the telemedicine usage between the patient and physician [6, 7].

Many countries, like the US, have initiated digital legal rules and regulations through policy initiatives [8]. The US defined the term US Centers for Medicare & Medicaid Services (CMS) for telemedicine, telemedicine-related terms [9]. Expansion of telemedicine in the US, including the payment parity, Insurance policies, and relaxed state licensure laws, etc. In March 2020, the U.S. HHS Office for Civil Rights (OCR) issued the Notification of Enforcement Discretion for telemedicine [10]. The Health Insurance Portability and Accountability Act (HIPAA) privacy and security enforcement was relaxed temporarily to support rapid telemedicine adoption [11]. Providers could use non-HIPAA compliant communication tools (Zoom, Skype, FaceTime) in good faith. ‘Red Flags’ and ‘Red Tape’ telemedicine and pharmacy-level barriers to buprenorphine in the United States were carried out [12].

In the context of telemedicine, triage refers to the structured, pre-consultation decision-making process that determines patient identity verification, urgency classification, eligibility for remote consultation, physician assignment, diagnostic pathway selection, and authorization for downstream actions such as prescription and pharmacy dispensing. Unlike traditional in-person triage, telemedicine triage is digitally mediated and integrates technical controls, ethical safeguards, and legal compliance mechanisms. In this study, triage is treated not as a single step, but as a continuous, workflow-level governance process spanning patient onboarding, consultation, prescription, and medication delivery.

Later, Indonesia [13] and the United States [14] understood that to treat telemedicine as a component of human rights in healthcare. Added more values on regulation, informed consent, medical records, licensing, and prescriptions. Indonesia faces legal threats due to unclear regulations. Recommends adopting U.S. legal frameworks for stronger certainty. Southeast Asia (Indonesia, Malaysia, Singapore, Thailand, Vietnam) countries for supporting Guidelines Comparison. 24 guideline documents analysed across Southeast Asian countries [15]. The Domains covered are governance, ICT infra, data storage, privacy, ethics, and security. Singapore had the most comprehensive guidelines. This work recommends universal guidelines adaptable to the local context. Also reveals the key gaps on patient ID, data ownership, cyber laws, and record disposal.

The EU considers eHealth a top priority, introducing digital health care, policies, frameworks, etc. [16]. Legislative and regulatory journey of telemedicine in Organisation for Economic Co-operation and Development (OECD) vs. non-OECD countries by adding stronger health system performance and Stakeholder collaboration essential for telemedicine planning and scalability [17]. India recommends stronger ethical frameworks within the guidelines [18]. But progress remains slow and inconsistent. Barriers: cultural resistance, poor infrastructure, lack of funding, and lack of IT skills. Recommends investment in public awareness, training, and national-level policies. Telemedicine in Brazil, The regulatory framework from the duration of 1990 to 2018, professional council regulations [19]. Used the advocacy coalition framework model. Finally, they conclude that despite many laws, Brazil still lacks a cohesive telemedicine regulatory framework.

Many countries keep promoting telemedicine growth by introducing several benefits and adaptations. Despite the rapid expansion of telemedicine platforms, existing studies and regulatory guidelines primarily address security, privacy, ethics, and legal compliance as isolated concerns or checklist-based requirements. There remains a lack of workflow-level governance models that explicitly operationalize telemedicine triage as a continuous decision-making process spanning patient authentication, consultation eligibility, tele-prescription, and pharmacy dispensing. Moreover, stakeholder accountability across physicians, pharmacies, platform providers, and regulators is weakly integrated into current technical and policy frameworks.

Accordingly, this study addresses the following research questions:

RQ1: How can telemedicine triage workflows be governed through an integrated Secure–Privacy–Ethical–Legal (SPEL) framework that is enforceable across all stages of remote care delivery?

RQ2: How can stakeholder-specific accountability and legal liability be systematically mapped to tele-consultation, tele-prescription, and medication dispensing processes within digital health systems?

The key contributions of this study are as follows:

1. A structured narrative synthesis of recent telemedicine research and policy documents, identifying governance-level gaps in existing security, privacy, ethical, and legal guidelines.
2. A triage-centric SPEL framework that operationalizes governance as a continuous, auditable workflow rather than a static compliance checklist.
3. A stakeholder accountability mapping, explicitly linking physicians, pharmacies, platform providers, and regulators to enforceable legal and ethical responsibilities across tele-consultation and tele-prescription processes.
4. A penalty-aware governance perspective, demonstrating how regulatory violations can be traced to specific workflow stages to support enforcement and compliance.

Despite extensive national-level telemedicine regulations and ethical guidelines, there is a lack of an integrated, stakeholder-aware, legally enforceable, and privacy-preserving global SPEL framework that operationalizes legal and ethical compliance across patients, physicians, hospitals, pharmacies, and manufacturers. Existing studies focus on isolated legal issues, country-specific policies, or ethical principles, but do not provide a unified operational SPEL framework with enforcement mechanisms.

This article will address the above three issues by introducing the telemedicine strategy to avoid any kind of legal and ethical violation among the stakeholders, the pharmacy, the physician, and the patient. the article is organized such a way of discussing on systematic review methodology in Section 2, literature review analysis is done in Section 3, structure systemic finding is discussion in Section 4, the legal and ethical issues in telemedicine/telemedicine in followed by the proposed telemedicine SPEL framework in Section 5, scenario-based validation of the SPEL framework is discussion Section 6, ethical and legal issues cases in and around the world in Section 7, research directions for future legal and ethical issues in Section 8, finally end with the conclusion in Section 9.

This section presents a comprehensive literature survey organized across five key dimensions of telemedicine security, privacy, ethics, legal considerations, and existing frameworks. The review begins by examining the rapid growth of telemedicine during the COVID-19 period, followed by a detailed discussion on privacy and security issues, ethical guidelines, various country-specific telemedicine initiatives, and prevailing legal challenges. The survey incorporates the most recent research articles published between 2020 and 2025.

3.1 Privacy and security threats in telemedicine workflows

A review on Protection of Patient Data in Digital Oral and General Health Care was done by Schofield [20] for Digital health and tele dentistry expanded during COVID-19. The article Metrics/Focus Areas: 24 articles reviewed (scoping review), Data security policies are most frequently studied and find gaps in: informed consent standards, clinical liability definitions, confidentiality measures. The authors' major concerns are data security, privacy, ethical risks, and inconsistent standards. Need for unified regulations and app control systems. Rise of “patient 4.0” increasing medico-legal pressures. A Systematic Review on Privacy and Security Risk Factors Related to Telemedicine Services was done by Bassan [21]. They identified privacy and security risk factors during telemedicine expansion (COVID-19 context). Risks classified into environmental, technology, and operational factors. Metrics/Findings from 18 empirical studies: Environmental: lack of private space, difficulty sharing sensitive info. Technology: weak data security, poor internet access. Operational: reimbursement issues, training gaps, tech accessibility. Finally, authors develop best practices for privacy in telemedicine, improve training for providers and patients, and expand policies ensuring technology accessibility and secure environments.

Despite extensive technical countermeasures, these studies largely treat security and privacy as system-level concerns, with limited attention to workflow-specific accountability or legal enforceability.

3.2 Consent management and clinical documentation

Pandya et al. [22] carried out the research review on telemedicine and ethics: opportunities in India, specifically focusing on ethical issues. Their review works reveal the following point to improve in India: telemedicine guidelines (2020) improve legal clarity. Ethical issues still unresolved: consent, documentation, patient identity verification, and autonomy. Recommends stronger ethical frameworks within the guidelines. The comparison of telemedicine-related ethics and guidelines and thechecklist for ethical decision making – behavioural analysis practice has been done by Kaplan [23] in the USA for supporting Ethics, ABA telemedicine. They compared ethics codes from psychology, paediatrics, and social work with ABA. Identified unique ethical concerns for ABA telemedicine that have not been addressed previously. Created a telemedicine readiness checklist (legal, professional, and ethical requirements).

3.3 Licensure, liability, and professional accountability

Discussing the Legal Aspects of the Use of AI in telemedicine was carried out by de Oliveira Andrade et al. [24], focusing on Global AI Law, Privacy, and Continuous Learning Systems. They point out the following points that AI plus telemedicine increases privacy and consent risks. Continuous learning systems create additional liability and ethical risks. Vulnerable groups (children, the elderly, and the severely ill) face issues with free consent. The study proposes safeguards and legal recommendations to minimize risks. Mazzuca et al. [25] have done a review on legal comparison of the use of telemedicine between Indonesia and the United States. Finally, this article reveals the following points: both countries treat telemedicine as a component of human rights in healthcare. Major differences: regulation, informed consent, medical records, licensing, prescriptions. Indonesia faces legal threats due to unclear regulations. Recommends adopting U.S. legal frameworks for stronger certainty.

Application fields, professional liability and focus on care services during the COVID-19 in Italy for telemedicine medical legal aspects of was discussed by Di Fede et al. [26] Legal issues include accreditation, confidentiality, consent, and developing parallel regulatory infrastructures, which strengthen legal clarity on liability and data protection. Finally, Italy’s telemedicine classifications: Specialized Telemedicine, Tele-healthcare, Tele-assistance for service centre, facility, healthcare worker. Houser et al. [27] discussed the following points in telemedicine expands access but introduces legal/regulatory challenges, Physician licensure becomes complex across states, Interstate Medical Licensure Compact provides simplified multistate licensure, Physician–patient relationship, informed consent, and standard of care gain added layers in telemedicine also projected providers must follow both state laws (provider location plus patient location) and federal laws (Ryan Haight Act, HIPAA, Stark Law, Anti-Kickback Statute). But the authors find the following points were difficult to address: Compliance burden across states (no direct metrics but regulatory complexity), Legal risk assessment (qualitative). Multistate licensure efficiency improved by the Compact (process metric).

The legal, regulatory, and ethical issues for cell phone stewardship framework was done by Aneja and Arora [28]. They evaluated WhatsApp usage data from 590 articles. Categorized issues into legal, regulatory, and ethical. Points highlighted are Rapid use of WhatsApp in clinical care requires oversight, identified legal, ethical, and regulatory challenges, and developed the Cell Phone Stewardship Framework for Healthcare Professionals (CSF-HCP). The author's recommendation was to promote “cell phone stewardship” and Formal adoption of CSF-HCP across healthcare organizations.

Baumes et al. [29] have done the ethical, legal, and social challenges in the development and implementation of disaster telemedicine. She evaluates the crisis standards of care and quality assurance, and preparedness indicators. And insist on the following point, telemedicine is critical during disaster response, raises ethical, social, and legal challenges, and needs disaster-specific telemedicine standards. The author recommends developing ethical frameworks for disaster telemedicine and creating public-private partnerships for scalable systems.

3.4 Cross-border telemedicine governance

Telemedicine in Middle Eastern countries, from Progress, barriers, and policy recommendations done by Solimini et al. [6] in the Middle East region. They find the Adoption Barriers, Policy, but this work also pointed out the following discussions: Progress remains slow and inconsistent. Barriers: cultural resistance, poor infrastructure, lack of funding, and lack of IT skills. Recommends investment in public awareness, training, and national-level policies. ‘Red Flags’ and ‘Red Tape’ telemedicine and pharmacy-level barriers to buprenorphine in the United States was carried out by Textor et al. [12]. This work was carried out with participant observations and semi-structured interviews: Patients (n = 19), prescribers (n = 24), pharmacists (n = 10) in PA and CA (2020–2021). The points highlighted in this article are COVID-19 enabled telemedicine exemptions for buprenorphine prescribing, but pharmacy barriers remained. Study examines telemedicine implementation for Opioid Use Disorder (OUD) treatment. Due to this work, telemedicine increased access, but pharmacies still imposed “red flags” and “red tape” such as geographic restrictions, cancellations, and refusals. Barriers led some patients to relapse into injection drug use. But limits on telemedicine alone cannot eliminate access barriers. Pharmacy-level practices influenced by DEA fears continue to restrict treatment, producing uneven policy impacts.

Intan Sabrina and Defi [30] have done a review on telemedicine Guidelines in Southeast Asia (Indonesia, Malaysia, Singapore, Thailand, Vietnam) for supporting Guidelines Comparison. 24 guideline documents analysed across SE Asian countries. The Domains covered are governance, ICT infra, data storage, privacy, ethics, and security. Singapore had the most comprehensive guidelines. This work recommends universal guidelines adaptable to the local context. Also reveals the key gaps on patient ID, data ownership, cyber laws, and record disposal. Bhate et al. [11] have shown the importance of the HIPAA and Accelerated telemedicine adoption during COVID-19 in the USA, which is titled HIPAA telemedicine adoption. This article highlighted that COVID-19 forced rapid telemedicine adoption; HIPAA enforcement was temporarily relaxed. Non-EMR apps are used widely but lack the required Audit Controls. Many apps are encrypted but still not HIPAA-compliant. Suggests revising HIPAA audit rules to improve care while protecting privacy. Highlights legal/ethical issues: liability, cybersecurity, scope of practice.

Misheva and Ampovska [31] discussed how telemedicine is becoming the new normal in the EU due to rapid digital transformation. The EU considers eHealth a top priority (Digital Health and Care 2018; EC 2019–2024 priorities). COVID-19 accelerated telemedicine integration into traditional systems. Major challenge: lack of telemedicine-specific legislation, policies, and governance frameworks in the EU and especially in North Macedonia.

Al-Alawy and Moonesar [32] mention the following points in their article: WHO defines health innovation as improving systems, products, technologies, services, and policies, especially for vulnerable populations. The study explored the legislative and regulatory journey of telemedicine in OECD vs. non-OECD countries. The sources reviewed: government documents, medical board reports, media, and peer-reviewed literature. Legislation/regulation essential for governance, accountability, safety, and security. No uniform global telemedicine legislation; countries use different strategies (including precautionary approaches). Telemedicine implementation styles vary widely. But need to move beyond regulation for stronger health system performance, and Stakeholder collaboration is essential for telemedicine planning and scalability.

3.5 Tele-prescription and pharmacy dispensing controls

Gallese Nobile [33] has done the implementation of a law enforcement–led pre-arrest diversion-to-treatment program for adults with substance use disorders. The study describes implementation and outcomes of a pre-arrest diversion program (MARI). This article focuses on Formative plus process evaluation, descriptive statistics, thematic qualitative analysis, and the dataset from Sept 2017–Aug 2020, and elaborates on the surveys from police, participants, and treatment staff. There were 263 participants who engaged and completed the program. Shachar et al. [34] highlighted the COVID-19 triggered rapid and unprecedented expansion of telemedicine in the US. Regulatory changes during PHE include: payment parity, relaxed HIPAA enforcement, and relaxed state licensure laws. The Payment parity addressed low reimbursement barriers; telemedicine visits increased from ~ 10% to > 90% in many clinics. Also, the privacy rules were relaxed, allowing non-HIPAA platforms (FaceTime, Zoom). States relaxed licensure rules; clinicians could treat across state borders.

Fields [35] emphasised that the telemedicine providers must comply with institutional, state, and federal regulations, and it is mandatory to obtain multistate licensing when providing care across state lines, as well as credentialing and privileging required at external facilities. Internet-based prescribing has legal restrictions and is allowed only under limited conditions. Also, the Malpractice insurance coverage for telemedicine varies by insurer, especially for interstate telemedicine. Telemedicine programs must uphold strict PHI protection. Ethical principles (autonomy, beneficence, non-maleficence, justice) apply equally to telemedicine and in-person care. Telemedicine has more similarities than differences with traditional practice. Need to streamline regulatory processes to unlock telemedicine’s full potential. But this work has a high administrative burden to comply with all federal/state rules.

Hoffman [36] pointed out the following points in his article. COVID-19 increased the need for telemedicine. Telemedicine reduces exposure, frees hospital resources, and improves access for rural areas. Regulators removed barriers rapidly. Telemedicine benefits will remain after COVID-19. Key focus areas for improvement: reimbursement, privacy and cybersecurity, liability, licensure, tech access, and AI integration. Need for monitoring how companies use transmitted personal health data. But this article finds some limitations on the legal services, telemedicine utilization rates during COVID, Regulatory compliance (HHS, FDA, state updates), Patient access indicators (rural vs. urban), and data security/cybersecurity compliance. De-metrics (Gaps), Inconsistent reimbursement models. Unclear malpractice and liability frameworks, technology access inequality, and limited AI regulations.

Silva et al. [37] have done three decades of telemedicine in Brazil, the regulatory framework from the duration of 1990 to 2018. Mapping and content analysis of 79 federal legislations with 31 professional council regulations. Used the advocacy coalition framework model. Finally, they conclude that despite many laws, Brazil still lacks a cohesive telemedicine regulatory framework.

Table 2. Thematic mapping of telemedicine governance literature

The thematic synthesis highlights in Table 2 that while telemedicine governance has been widely studied, existing approaches remain fragmented across technical, ethical, and legal dimensions. Security and privacy solutions are predominantly system-centric, consent mechanisms lack downstream enforceability, liability models are jurisdiction-bound, and pharmacy-level controls are insufficiently governed. Crucially, no existing SPEL framework integrates these dimensions into a unified, triage-centric workflow with explicit stakeholder accountability and enforceable legal mapping. This gap motivates the development of the proposed SPEL framework.

From the literature survey, many authors were discussing the security, privacy, legal, and ethical challenges in telemedicine handled by different countries. Even though the globalized SPEL framework, which supports all telemedicine challenges, was not invented by any inventor. The proposed SPEL framework operationalizes telemedicine triage as a legally enforceable and ethically governed triage-centric telemedicine workflow, where access control, consultation eligibility, prescription authorization, and pharmacy dispensing are all treated as sequential triage decisions. This section proposed a SPEL Framework, which will monitor or handle the telemedicine routing work, also supporting the patient, physician, pharmacy, and hospitals from violating ethical and legal issues. Figure 1 depicts the proposed SPEL framework, which has nine major process components, and each component is related to or connected to other components to achieve the globalized proposed SPEL framework. Each process component is named as Secure, Privacy, Ethical, Legal, Stakeholder, Pharmacy, Hospital, Patient, and Physician. The operational principle involved in each process is connected to other processes. Simple one-time password generation is majorly involved in the SPEL framework operation to ensure ethical and legal avoidance.

Figure 1. Secure–Privacy–Ethical–Legal (SPEL) telemedicine framework

5.1 Threat model for triage-centric telemedicine workflows

The proposed SPEL framework assumes an adversarial environment encompassing both external and internal threat actors. The primary threat categories considered include:

(i) External attacks, such as unauthorized access, credential theft, and interception of telemedicine communications;

(ii) Insider misuse, including unauthorized data access by clinicians, platform administrators, or pharmacy staff;

(iii) Workflow abuse, such as prescription manipulation, illegal dispensing, or bypassing consent requirements; and

(iv) Secondary data misuse, involving unauthorized data sharing for non-clinical or commercial purposes.

These threats are analyzed across the full telemedicine triage workflow, spanning patient onboarding, consultation, tele-prescription, pharmacy dispensing, and data retention.

Table 4 discusses the minimum required controls and its purpose.

Table 4. Minimum technical and organizational controls in the Secure–Privacy–Ethical–Legal (SPEL) framework

5.2 Role and limitations of one-time password in the Secure–Privacy–Ethical–Legal framework

Within the SPEL framework, one-time passwords (OTPs) are employed as a first-layer authentication mechanism to verify user presence and session legitimacy during critical workflow transitions, such as login, prescription authorization, and pharmacy verification. OTPs are effective against credential reuse, replay attacks, and certain forms of external intrusion. However, OTPs alone are insufficient to mitigate insider misuse, privilege abuse, or unauthorized secondary data sharing. For these risks, the SPEL framework explicitly relies on role-based access control (RBAC), action-level audit logging, consent-bound data access, and enforceable retention and deletion policies. OTPs, therefore, function as a gatekeeping mechanism rather than a comprehensive security solution.

5.3 Mitigating insider misuse and secondary data sharing

Insider threats and secondary data misuse represent governance risks that cannot be adequately addressed through authentication alone. In the SPEL framework, insider misuse is mitigated through least-privilege role assignment, continuous audit logging of data access and modifications, and post-hoc legal traceability enabled by immutable records. Secondary data sharing is controlled through purpose-limited consent capture, role-specific data views, and policy-enforced retention and deletion mechanisms. These controls collectively ensure that data access is both technically constrained and legally attributable.

5.4 Legal and ethical framework

The legal and ethical framework is a library for handling ethical issues. For example, users entered the wrong OTP many times, trying to access the private data, stakeholder rules violation, pharmacy fraud, hospital-related issues, patient and Physician relationship, payment, etc. Tables 5-7 state the punishment in telemedicine legal issues globally in all kinds of processes. Steps involving the legal and ethical framework process are given below.

The following Tables 5-7 summarize penalties by legal regime. Each jurisdiction has distinct enforcement mechanisms and penalty structures; they are not interchangeable

Table 5. Penalties for data protection violations in India

Table 6. Penalties under General Data Protection Regulation (GDPR) (EU)

Table 7. Penalties under Health Insurance Portability and Accountability Act (HIPAA) (US)

Hageseth v. Superior Court in the USA [38], a psychiatrist licensed in Colorado prescribed fluoxetine via the Internet to a patient in California, without a face-to-face evaluation. The patient later died by suicide. The court convicted the doctor of practicing medicine without a license, which underscores jurisdiction/licensure issues in remote prescribing and the risk of serious harm if remote evaluation is inadequate. Telemedicine malpractice and standard‑of‑care lawsuits [40] in the USA, Cases where remote consultations (e.g., for ear pain, dermatology via photo uploads) led to misdiagnosis or missed diagnosis (e.g., melanoma), claims argued a lack of in‑person exam or informed consent. As highlighted in malpractice law literature, reinforces that telemedicine must meet the same standard of care as in‑person care; tele‑providers are liable for negligence even if consultation was virtual. Cross‑state / interstate telemedicine liability and regulatory conflicts [36] in the USA, in federated systems, licensing boards may not have enforcement over out-of-state providers; jurisdictional complexity hampers accountability for cross‑state telemedicine. Regulatory ambiguity, cross‑state telemedicine may evade standard oversight, complicating malpractice claims/liability/professional discipline. Regulatory‑board restrictions: prior in‑person requirement for electronic consultation [41] in the USA. Historically, in some states (e.g., Idaho), electronic-only consultations/prescriptions were disallowed; in other states, providers challenged such rules (e.g., Teladoc Health vs. state boards). Demonstrates how regulation (or its absence) can limit or enable telemedicine; restrictive rules can hinder access, especially affecting rural/underserved areas, but relaxations may bring regulatory risk or compromise quality.

Early medico‑legal analysis: Telemedicine in India: an ethical and medico‑legal perspective in India [42], highlighted the lack of a clear-cut legal/regulatory framework for telemedicine; identified medico‑legal issues: doctor–patient. relationship, consent, confidentiality, medical negligence, liability, licensing, and jurisdiction. Shows that even where telemedicine is used, a lack of formal regulation can lead to legal/ethical ambiguity, risk for both providers and patients in virtual care delivery. Recent legal‑ethical review: Legal Challenges and Considerations in Implementing Telemedicine Services [43] in India, Analysis of existing guidelines (e.g. Telemedicine Practice Guidelines, Medical Council and IT law), found gaps related to licensing, liability, credentialing, data privacy; also raised ethical issues: informed consent, equitable access, patient privacy, maintenance of care quality in virtual consultations. Underlines continuing legal and ethical vulnerabilities in telemedicine practice in India, especially regarding privacy, consent, liability, and equitable access in rural/underserved contexts. Ethical and legal aspects of telepsychiatry [44] in India, as telepsychiatry grows, need for explicit definitions: what constitutes a valid virtual consultation, prescription modes, documentation, and eligible platforms; current frameworks are inadequate for some aspects. Emphasizes that specialty tele‑services (e.g., psychiatry) via telemedicine require clearer legal/ethical standards to ensure safe, responsible remote care.

In a systematic review of telemedicine during COVID‑19, e.g., a study from Brazil [45], rural populations had difficulty accessing telemedicine due to a lack of infrastructure, limited digital literacy, and a lack of regulation, concerns around data confidentiality/security, challenges in lab tests, prescriptions, and diagnostics. Demonstrates that in LMICs, rural/infrastructure limitations make telemedicine risky: quality of care, confidentiality, and equitable access threaten to worsen health disparities. Same review remote monitoring and telemedicine for heart disease / general care [46] in ITALY, Problems: low patient adherence/cooperation, poorly structured data management, device issues, data privacy, lack of uniform reimbursement, informed consent, and training gaps; telemedicine not suitable for emergencies; diagnostics limitations. Highlights that even in higher‑income countries, telemedicine faces cultural, systemic, regulatory, and technological hurdles; quality, privacy, reimbursement, and standardization remain issues.

Rural hospitals – computer‑mediated synchronous communication study: Improving Computer‑Mediated Synchronous Communication of Doctors in Rural Communities through Cloud Computing [47] in South Africa, found that rural hospitals attempted tele‑consultation / remote advice via computer-mediated tools, but frequent internet slowness, power outages, lack of e‑health software, and poor connectivity hindered use. Demonstrates infrastructural and reliability barriers in rural/remote settings, telemedicine adoption is heavily constrained by connectivity/power, limiting scalability and equity. Brilliant AI Doctor in Rural China: Tensions and Challenges in AI‑Powered CDSS Deployment [48] in China (rural clinics), Implementation of AI‑powered clinical decision support systems (CDSS) in rural clinics, but clinicians reported misalignment with local workflows, technical limitations, usability barriers, limited transparency and trust; concerns about reliability. Raises ethical and practical concerns about deploying AI/Telemedicine jointly in rural/low‑resource contexts: trust, usability, data quality, transparency, i.e., tele‑solutions cannot be “one‑size‑fits‑all.” Ethical and legal challenges of telemedicine in the era of the COVID-19 pandemic [49] in Multiple Countries (Global / Cross‑jurisdiction), Found common issues across countries: informed consent, patient privacy/confidentiality, data protection/security, malpractice / professional liability, equity of access, quality of care, doctor–patient relationship, telemedicine often treated as supplement to in‑person care rather than replacement. Indicates that regardless of country, telemedicine without robust regulation and safeguards carries risks [50]; privacy, equity, liability, and quality of care must be well-managed.